These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18080051)

  • 1. Prevalence of screening in patients newly diagnosed with colorectal cancer in Ontario.
    Taylor C; Schultz SE; Paszat LF; Bondy S; Rabeneck L
    Can J Gastroenterol; 2007 Dec; 21(12):805-8. PubMed ID: 18080051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L; Paszat LF
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New trend in colorectal cancer in Germany: are young patients at increased risk for advanced colorectal cancer?
    Ambe PC; Jansen S; Zirngibl H
    World J Surg Oncol; 2017 Aug; 15(1):159. PubMed ID: 28835275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests.
    Lee YC; Fann JC; Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Hsu CY; Hsu WF; Wu MS; Chen HH
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1332-1340.e3. PubMed ID: 30391435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
    Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
    Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro.
    Panic N; Rösch T; Smolovic B; Radunovic M; Bulajic M; Pavlovic-Markovic A; Krivokapic Z; Djuranovic S; Ille T; Bulajic M
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1222-5. PubMed ID: 26067224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
    Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical stages of colorectal cancer diagnosed in obese and overweight individuals in the Polish Colonoscopy Screening Program.
    Spychalski P; Kobiela J; Wieszczy P; Kamiński MF; Reguła J
    United European Gastroenterol J; 2019 Jul; 7(6):790-797. PubMed ID: 31316783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with symptom- and screening-detected colorectal cancer.
    Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
    Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
    van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
    United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal Cancer Identification Methods Among Kansas Medicare Beneficiaries, 2008-2010.
    Lai SM; Jungk J; Garimella S
    Prev Chronic Dis; 2015 Jul; 12():E107. PubMed ID: 26160293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Danish national strategy for selective use of colonoscopy in symptomatic outpatients without known risk factors for colorectal cancer.
    Bjerregaard NC; Tøttrup A; Sørensen HT; Laurberg S
    Scand J Gastroenterol; 2007 Feb; 42(2):228-36. PubMed ID: 17327943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of a colorectal cancer screening programme: results from a single-centre study.
    Vermeer NCA; Bahadoer RR; Bastiaannet E; Holman FA; Meershoek-Klein Kranenbarg E; Liefers GJ; van de Velde CJH; Peeters KCMJ
    Colorectal Dis; 2018 Sep; 20(9):O239-O247. PubMed ID: 29917325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study.
    Lakoff J; Paszat LF; Saskin R; Rabeneck L
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1117-21; quiz 1064. PubMed ID: 18691942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis.
    Bressler B; Paszat LF; Chen Z; Rothwell DM; Vinden C; Rabeneck L
    Gastroenterology; 2007 Jan; 132(1):96-102. PubMed ID: 17241863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of synchronous colorectal neoplasms detected by colonoscopy in patients with gastric cancer.
    Saito S; Hosoya Y; Togashi K; Kurashina K; Haruta H; Hyodo M; Koinuma K; Horie H; Yasuda Y; Nagai H
    Surg Today; 2008; 38(1):20-5. PubMed ID: 18085357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current screening guidelines overlook a significant number of patients treated for colorectal cancer.
    Przybyla AG; Crockett JA; Rex JC; Culumovic PJ
    Am Surg; 2014 Jun; 80(6):539-43. PubMed ID: 24887789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in CRC Prevention: Screening and Surveillance.
    Dekker E; Rex DK
    Gastroenterology; 2018 May; 154(7):1970-1984. PubMed ID: 29454795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.